Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

European Commission authorises twice-yearly Yeytuo (lenacapavir) for HIV prevention – Gilead Sciences

Written by | 30 Aug 2025

Gilead Sciences Inc. announced that the European Commission (EC) has granted marketing authorization for Yeytuo (lenacapavir)—the company’s twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to… read more.

New research supports Ivermectin as an effective strategy to control malaria transmission

Written by | 28 Jul 2025

Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease. The BOHEMIA trial, the largest study on ivermectin for malaria… read more.

Vaccination support program reduces pneumonia-related mortality by 25 percent among the elderly

Written by | 6 Jul 2025

A research team has evaluated the real-world impact of a community-based pneumococcal vaccination support program for older adults conducted in Sera Town, Hiroshima Prefecture, Japan. Their work is… read more.

Prescribing fewer antibiotics might not be enough to combat threat of ‘superbugs,’ says new research

Written by | 25 Jun 2025

Antimicrobial resistance is still spreading in the environment despite a reduction in the amounts of antibiotic drugs prescribed, according to a new study led by the University of… read more.

Excessive use of disinfectants in intensive care patients may increase the risk of antibiotic-resistant infections

Written by | 23 Jun 2025

An international study has, for the first time, revealed a strong and direct link between the rise of antibiotic-resistant bacteria and universal disinfection procedures applied to patients in intensive care… read more.

Every dose counts: Safeguarding the success of vaccination in Europe

Written by | 5 May 2025

Marking European Immunization Week (EIW) 2025, the European Centre for Disease Prevention and Control (ECDC) highlights the risks of suboptimal vaccination coverage in Europe and publishes a set… read more.

Many patients with chlamydia and gonorrhea are not receiving CDC-recommended treatment in primary care

Written by | 29 Mar 2025

Background and Goal: Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce transmission. Adherence to the Centers for Disease Control… read more.

Roche receives FDA clearance with CLIA waiver for cobas liat molecular tests to diagnose sexually transmitted infections at the point of care

Written by | 29 Jan 2025

Roche announced that the FDA  has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat sexually transmitted infection (STI) multiplex assay… read more.

Study shows drop in use of antiviral medications in young children with influenza

Written by | 21 Dec 2024

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. “Antiviral Use Among… read more.

Breakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot

Written by | 17 Dec 2024

As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work… read more.

Around 1 in 5 of the world’s under 50s living with genital herpes

Written by | 12 Dec 2024

Around 1 in 5 of the world’s under 50s—846 million people—are living with genital herpes infection, suggest the latest global estimates, published online in the journal Sexually Transmitted Infections…. read more.

U of M study demonstrates efficacy of iron supplements for children living with HIV

Written by | 12 Nov 2024

A University of Minnesota Medical School research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.